EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon

Adila L B Dias, Joabi Rocha Nascimento, José Diego Brito-Sousa, Marco Aurelio Sartim iD, Kamilla Freitas da Silva, Alexandre Vilhena Silva-Neto, Gabriel Dos Santos Mouta iD, Patricia Carvalho da Silva Balieiro, Djane Clarys Baia-da-Silva, Fernando Almeida-Val iD, Gisely Cardoso de Melo, Vanderson de Souza Sampaio iD und 2 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0331729 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS One, 2025. Verfasst von Adila L B Dias und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil. Hauptthemen laut MEDLINE: COVID-19, Glucosephosphate Dehydrogenase Deficiency. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado do Amazonas, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is a common genetic disorder that impairs the cellular antioxidant response and has been hypothesized as a potential risk factor for severe outcomes in viral infections, including COVID-19. However, clinical evidence remains limited, especially in regions with high G6PDd prevalence.

Methods

We conducted a retrospective cohort study using secondary data from four health information systems from health facilities in the Brazilian Amazon (E-SUS Notifica, SIVEP-Gripe, SIM, and a G6PD enzyme activity database). The study population consisted of 3,955 male participants, including 206 with confirmed G6PDd. We used logistic regression to assess associations between G6PDd and COVID-19 infection, hospitalization, and death. Cox proportional hazards models and Kaplan-Meier curves were applied to evaluate time-to-event outcomes.

Results

No statistically significant association was found between G6PDd and SARS-CoV-2 infection (OR = 1.15; 95% CI: 0.70–1.79; p = 0.6), hospitalization (OR = 1.13; 95% CI: 0.27–3.20; p = 0.8), or death (OR = 0.00; p > 0.9). Age was a significant risk factor for all outcomes, and individuals identified as Asian had a higher likelihood of infection (OR = 2.87; 95% CI: 1.57–5.29; p < 0.001).

Conclusion

In this cohort from the Brazilian Amazon, G6PD deficiency was not associated with an increased risk of COVID-19 infection or severe outcomes. These findings emphasize the importance of considering ethnic and genetic diversity in epidemiological analyses and health policy planning, particularly in regions with high G6PDd prevalence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Glucosephosphate Dehydrogenase DeficiencyHumansMaleBrazilMiddle AgedAdultRetrospective StudiesSARS-CoV-2AgedHospitalizationRisk FactorsSeverity of Illness IndexYoung AdultAdolescentFemaleKaplan-Meier Estimate

Autor:innen und Institutionen

  • Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.
  • Escola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Manaus, Brazil.
  • Instituto de Pesquisas Leônidas & Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil.
  • Faculdade de Ciências Farmacêuticas, Universidade Federal do Amazonas, Manaus, Brazil.
  • Università degli Studi di Siena, Siena, Italy.
  • Universidade Nilton Lins, Manaus, Brazil.

ORCID-Profile: Marco Aurelio Sartim, Gabriel Dos Santos Mouta, Fernando Almeida-Val, Vanderson de Souza Sampaio, Wuelton Monteiro

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado do Amazonas
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Dias, A. L. B., Nascimento, J. R., Brito-Sousa, J. D., Sartim, M. A., da Silva, K. F., Silva-Neto, A. V., Dos Santos Mouta, G., da Silva Balieiro, P. C., Baia-da-Silva, D. C., Almeida-Val, F., de Melo, G. C., Sampaio, V. S., Lacerda, M., & Monteiro, W. (2025). Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon. PLOS One. https://doi.org/10.1371/journal.pone.0331729

Vancouver

Dias ALB, Nascimento JR, Brito-Sousa JD, Sartim MA, da Silva KF, Silva-Neto AV, et al. Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon. PLOS One. 2025. doi:10.1371/journal.pone.0331729

BibTeX
@article{Dias2025,
  author = {Dias, Adila L B and Nascimento, Joabi Rocha and Brito-Sousa, José Diego and Sartim, Marco Aurelio and da Silva, Kamilla Freitas and Silva-Neto, Alexandre Vilhena and Dos Santos Mouta, Gabriel and da Silva Balieiro, Patricia Carvalho and Baia-da-Silva, Djane Clarys and Almeida-Val, Fernando and de Melo, Gisely Cardoso and Sampaio, Vanderson de Souza and Lacerda, Marcus and Monteiro, Wuelton},
  title = {Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331729}
}
Kostenlos starten →